QuickMD Expands Services in 11 States
Expansion brings QuickMD’s addiction treatment program to 44 states and Washington, D.C., while extending mental health care across 13 states.
LOS ANGELES, September 1, 2026 — QuickMD, one of the largest direct-to-consumer telemedicine platforms in the U.S., today announced two expansions of its virtual care services, bringing addiction treatment to Montana and extending its mental health services to 10 additional states. QuickMD will launch its Medication-Assisted Treatment program for opioid use disorder in Montana on September 1, 2026. The company already offers weight loss consultations and urgent care in the state.
Eligible adults will be able to meet privately by phone or video with licensed clinicians experienced in addiction treatment. When appropriate, clinicians may prescribe medications such as buprenorphine-naloxone (Suboxone®) to help manage opioid cravings and withdrawal.
“For someone who is ready to begin treatment, distance, stigma or a long wait should not stand in the way,” said Dr. Robert Stern, M.D., Chief Medical Officer of QuickMD. “Opioid use disorder is treatable, and timely access to evidence-based care can make a meaningful difference in a patient’s ability to move forward. Expanding into Montana will make it easier for more people to connect with an experienced clinician and begin care.”
QuickMD is also expanding its mental health service line, which was initially launched in New York, North Carolina and Mississippi. Mental health services are now available in Alabama, Florida, Georgia, Mississippi, Missouri, New Jersey, New York, North Carolina, Ohio, South Carolina, Virginia, Washington and Wisconsin.
The expansion increases QuickMD’s mental health footprint to 13 states, giving more patients access to licensed clinicians through telemedicine for mental health evaluation and ongoing care.
“We’re continuing to expand in the areas where we believe telemedicine can remove meaningful barriers to care,” said Matt Gove, Chief Growth Officer of QuickMD. “That means expanding the nation’s largest telemedicine treatment platform to more communities while also making mental health care available to significantly more patients. Having successfully grown our mental health footprint to 13 states, we are planning to expand to even more states in the near future. Both expansions reflect the same goal of helping people get high-quality care more easily, wherever they are.”
QuickMD addiction treatment visits cost $99, with no insurance or referral required. Same-day visits are often available seven days a week. Prescriptions are provided only when clinically appropriate and are not guaranteed. QuickMD has completed more than 1.5 million patient visits across addiction treatment, weight loss, women’s health, and other areas of care.
Adults in Montana can learn more about addiction treatment at QuickMD.com. Mental health services are currently available to eligible patients in participating states.
About QuickMD
QuickMD is one of the largest direct-to-consumer telemedicine platforms in the U.S., with more than 1.5 million patient visits completed. The company specializes in Medication-Assisted Treatment (MAT) for opioid use disorder and 7-OH and kratom dependence, and also offers women’s hormone therapy, mental health care, weight management, and urgent care. Through its nationwide network of experienced clinicians, QuickMD helps patients get care quickly, wherever they are.
Media contact
Jacob Ehrlich
VP, Marketing
jacob@quick.md